Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Haematologica. 2011 Mar;96(3):349-52. doi: 10.3324/haematol.2010.030023.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers, Tumor / analysis
  • Chromosome Aberrations
  • Disease-Free Survival
  • Humans
  • Kaplan-Meier Estimate
  • Mutation
  • Myelodysplastic Syndromes / classification*
  • Myelodysplastic Syndromes / mortality
  • Myelodysplastic Syndromes / physiopathology
  • Myeloproliferative Disorders / classification*
  • Myeloproliferative Disorders / mortality
  • Myeloproliferative Disorders / physiopathology
  • Prognosis
  • Risk Assessment

Substances

  • Biomarkers, Tumor